The TESTBREAST study: early detection of breast cancer in women at high risk of developing breast cancer with serum biomarkers.

Completed

• Conditions: breast cancer; 10006291; 10006232

• Registration Number: NL-OMON53091
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1193

Inclusion Criteria

- women
- 25-75 years old
- indication for frequent surveillance (twice a year) because of genetic or
familial high risk of developing breast cancer or life time risk of more 15
percent.

Exclusion Criteria

- breast cancer in medical history
- malignancy in de past 10 years (excl. basalcell carcinoma)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Early detection of breast cancer by analysing protein and glycan profiles.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To analyse the prognostic value of protein and glycan profiles secundary<br /><br>parameters are 5 years survival, disease free period and distant mestastasis</p><br>